BBH vs. JAGLX

Last updated Jun 5, 2026

BBH (VanEck Vectors Biotech ETF) and JAGLX (Janus Henderson Global Life Sciences Fund Class T) are both Health & Biotech Equities funds. BBH is passively managed, while JAGLX is actively managed. Over the past 10 years, BBH returned 5.85%/yr vs 10.94%/yr for JAGLX. Their correlation of 0.81 suggests significant overlap in exposure. BBH charges 0.35%/yr vs 0.92%/yr for JAGLX.

Performance

BBH vs. JAGLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Biotech ETF (BBH) and Janus Henderson Global Life Sciences Fund Class T (JAGLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBH achieves a 0.12% return, which is significantly higher than JAGLX's -2.55% return. Over the past 10 years, BBH has underperformed JAGLX with an annualized return of 5.85%, while JAGLX has yielded a comparatively higher 10.94% annualized return.

BBH

• 1D: 2.00%
• 1M: 1.68%
• YTD: 0.12%
• 6M: -2.71%
• 1Y: 25.97%
• 3Y*: 6.79%
• 5Y*: 0.71%
• 10Y*: 5.85%

JAGLX

• 1D: 1.14%
• 1M: -0.31%
• YTD: -2.55%
• 6M: -0.80%
• 1Y: 26.04%
• 3Y*: 11.36%
• 5Y*: 8.05%
• 10Y*: 10.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBH vs. JAGLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBH VanEck Vectors Biotech ETF	0.12%	21.18%	-4.29%	3.94%	-15.25%	11.81%	22.13%	26.34%	-10.70%	16.46%
JAGLX Janus Henderson Global Life Sciences Fund Class T	-2.55%	24.72%	8.50%	7.41%	-2.79%	6.66%	25.52%	29.12%	4.05%	22.13%

Correlation

The correlation between BBH and JAGLX is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.81
Correlation (3Y) Calculated over the trailing 3-year period	0.80
Correlation (5Y) Calculated over the trailing 5-year period	0.81
Correlation (10Y) Calculated over the trailing 10-year period	0.83
Correlation (All Time) Calculated using the full available price history since Nov 24, 1999	0.81

The correlation between BBH and JAGLX has been stable across timeframes, ranging from 0.80 to 0.83 - a consistent structural relationship.

Return for Risk

BBH vs. JAGLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBH

BBH Risk / Return Rank: 41
BBH Sharpe Ratio Rank: 39
BBH Sortino Ratio Rank: 40
BBH Omega Ratio Rank: 37
BBH Calmar Ratio Rank: 51
BBH Martin Ratio Rank: 40

JAGLX

JAGLX Risk / Return Rank: 42
JAGLX Sharpe Ratio Rank: 40
JAGLX Sortino Ratio Rank: 40
JAGLX Omega Ratio Rank: 37
JAGLX Calmar Ratio Rank: 53
JAGLX Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBH vs. JAGLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Janus Henderson Global Life Sciences Fund Class T (JAGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBH	JAGLX	Difference
Sharpe ratio: Return per unit of total volatility	1.37	1.78	-0.42
Sortino ratio: Return per unit of downside risk	2.02	2.60	-0.58
Omega ratio: Gain probability vs. loss probability	1.24	1.31	-0.07
Calmar ratio: Return relative to maximum drawdown	2.47	2.73	-0.26
Martin ratio: Return relative to average drawdown	6.28	8.66	-2.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBH vs. JAGLX - Sharpe Ratio Comparison

The current BBH Sharpe Ratio is 1.37, which is comparable to the JAGLX Sharpe Ratio of 1.78. The chart below compares the historical Sharpe Ratios of BBH and JAGLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BBH	JAGLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.37	1.78	-0.42
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	0.51	-0.47
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.26	0.63	-0.37
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.58	-0.19

Drawdowns

BBH vs. JAGLX - Drawdown Comparison

The maximum BBH drawdown since its inception was -72.70%, which is greater than JAGLX's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BBH and JAGLX.

Drawdown Indicators

	BBH	JAGLX	Difference
Max Drawdown Largest peak-to-trough decline	-72.70%	-58.96%	-13.74%
Max Drawdown (1Y) Largest decline over 1 year	-10.55%	-9.71%	-0.84%
Max Drawdown (3Y) Largest decline over 3 years	-22.74%	-17.41%	-5.33%
Max Drawdown (5Y) Largest decline over 5 years	-39.86%	-22.25%	-17.61%
Max Drawdown (10Y) Largest decline over 10 years	-39.86%	-27.38%	-12.48%
Current Drawdown Current decline from peak	-12.08%	-5.47%	-6.61%
Average Drawdown Average peak-to-trough decline	-20.75%	-17.43%	-3.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.14%	3.05%	+1.09%

Volatility

BBH vs. JAGLX - Volatility Comparison

VanEck Vectors Biotech ETF (BBH) has a higher volatility of 6.37% compared to Janus Henderson Global Life Sciences Fund Class T (JAGLX) at 4.81%. This indicates that BBH's price experiences larger fluctuations and is considered to be riskier than JAGLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBH	JAGLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.37%	4.81%	+1.56%
Volatility (6M) Calculated over the trailing 6-month period	14.42%	10.89%	+3.53%
Volatility (1Y) Calculated over the trailing 1-year period	19.10%	14.86%	+4.24%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.50%	15.92%	+5.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.18%	17.41%	+4.77%

BBH vs. JAGLX - Expense Ratio Comparison

BBH has a 0.35% expense ratio, which is lower than JAGLX's 0.92% expense ratio.

Dividends

BBH vs. JAGLX - Dividend Comparison

BBH's dividend yield for the trailing twelve months is around 0.50%, less than JAGLX's 4.65% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBH VanEck Vectors Biotech ETF	0.50%	0.51%	0.80%	0.43%	0.47%	0.21%	0.36%	0.34%	0.50%	0.55%	0.30%	0.27%
JAGLX Janus Henderson Global Life Sciences Fund Class T	4.65%	4.53%	10.98%	4.22%	0.14%	9.78%	7.75%	6.17%	13.38%	0.89%	1.13%	9.09%

Frequently Asked Questions

Can I hold both BBH and JAGLX in my portfolio?

BBH and JAGLX have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBH or JAGLX?

BBH has higher volatility (6.37%) compared to JAGLX (4.81%). In terms of maximum drawdown, BBH dropped -72.70% vs JAGLX's -58.96%.

Which has better risk-adjusted returns?

JAGLX currently has the higher Sharpe Ratio (1.78 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.